gemadol retard 100 mg depotkapsler
viatris aps - tramadolhydrochlorid - depotkapsler - 100 mg
gemadol retard 150 mg depotkapsler
viatris aps - tramadolhydrochlorid - depotkapsler - 150 mg
gemadol retard 200 mg depotkapsler
viatris aps - tramadolhydrochlorid - depotkapsler - 200 mg
duspatalin retard 200 mg depotkapsler, hårde
viatris aps - mebeverinhydrochlorid - depotkapsler, hårde - 200 mg
gemadol retard 50 mg depotkapsler
viatris aps - tramadolhydrochlorid - depotkapsler - 50 mg
spasmo-lyt depot 60 mg depotkapsler, hårde
viatris aps - trospiumchlorid - depotkapsler, hårde - 60 mg
odrik 2 mg kapsler, hårde
viatris aps - trandolapril - kapsler, hårde - 2 mg
odrik 0,5 mg kapsler, hårde
viatris aps - trandolapril - kapsler, hårde - 0,5 mg
pirfenidone viatris
viatris limited - pirfenidon - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunosuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - narkotika anvendt i diabetes - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 og 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.